Quest Diagnostics Reports the Acquisition of LifeLabs from OMERS for an Aggregate of ~$985M
Shots:
- Quest Diagnostics has signed a definitive agreement to acquire LifeLabs from OMERS to improve diagnostic solutions across Canada
- Quest will acquire 100% of LifeLabs’ shares for an aggregate of ~$985M with the transaction concluding in the YE’24, contingent upon customary closing conditions & approvals (Canadian regulatory approvals); further terms were undisclosed
- After acquisition, LifeLabs will keep its brand, Canadian headquarters & management, with Quest offering new expertise, innovations & resources such as improved online appointment scheduling and faster patient service centre processing to enhance services. Quest will also improve LifeLabs' data security, ensuring Canadian health data remains in Canada
Ref: Quest Diagnostics | Image: Quest Diagnostics
Related News:- Quest Diagnostics Reports the Acquisition of Lab Assets from Allina Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
